- Report
- May 2025
- 140 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- May 2025
- 120 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- August 2025
- 89 Pages
Global
From €3500EUR$4,195USD£3,096GBP
- Report
- April 2025
- 84 Pages
Global
From €3500EUR$4,195USD£3,096GBP
- Report
- March 2025
- 86 Pages
Global
From €3500EUR$4,195USD£3,096GBP
- Report
- March 2025
- 85 Pages
Global
From €3500EUR$4,195USD£3,096GBP
- Report
- March 2026
- 234 Pages
Germany
From €4335EUR$4,850USD£3,705GBP
- Report
- March 2026
- 235 Pages
India
From €4335EUR$4,850USD£3,705GBP
- Report
- March 2026
- 233 Pages
Canada
From €4335EUR$4,850USD£3,705GBP
- Report
- March 2026
- 242 Pages
China
From €4335EUR$4,850USD£3,705GBP
- Report
- February 2026
- 183 Pages
Canada
From €4335EUR$4,850USD£3,705GBP
- Report
- February 2026
- 185 Pages
India
From €4335EUR$4,850USD£3,705GBP
- Report
- January 2024
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- February 2026
- 192 Pages
China
From €4335EUR$4,850USD£3,705GBP
- Report
- August 2025
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- August 2025
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- July 2025
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- July 2025
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- April 2025
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- April 2025
- 150 Pages
Global
From €4335EUR$4,850USD£3,705GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more